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Neurotrophins in healthy and diseased skin
C. Pincelli School of Biosciences and Biotechnologies, University of Modena and 
Reggio Emilia, Italy
Neurotrophins (NT) exert their functions through two transmembrane receptors, the 
low-affi nity receptor p75 (p75NTR) and the high-affi nity receptors trks. NT form a 
complex network at the skin level involving most cell types and resulting in a number 
of autocrine and paracrine activities. Basal keratinocytes secrete biologically active 
NGF, NT-3, BDNF and NT-4. Furthermore, human keratinocytes express p75NTR, 
trkA and trkC. Autocrine NGF stimulates keratinocyte proliferation through its high 
affi nity receptor trkA, while K252, a specifi c inhibitor of trk phosphorylation, blocks 
this effect. In addition, K252 and anti-NGF antibodies, induce apoptosis in human 
keratinocytes, indicating that autocrine NGF protects these cells from programmed cell 
death through its high affi nity receptor.  While NGF, released from keratinocytes, exert 
neurotropic properties and stimulate dendricity in melanocytes, these cells produce 
all NT in different amounts. UVB upregulate the release of NT-4 by keratinocytes that 
can act in a paracrine manner on melanocytes. Melanocytes in turn produce all NT, but 
release only NT-4. Melanocytes treated with TPA express TrkA and TrkB, but not TrkC. 
NT fail to stimulate melanocyte proliferation, whereas they stimulate the synthesis of 
tyrosinase. NT-4, which is the only NT released by melanocytes acts in an autocrine 
manner to stimulate melanogenesis. Both dermal fi broblasts (DF) and myofi broblasts 
(MF) synthesize and release all NTs. In addition, DF and MF express all NT receptors 
except for trkC. NGF, BDNF, NT3 or NT4 promote fi broblasts differentiation into 
myofi broblasts, as they induce α-sma expression with an effect similar to the one 
produced by TGF-β Moreover, NGF and BDNF, but not NT-3 and NT-4 stimulate 
isometric contractile strengths in living dermal equivalents, as measured by the 
Glasbox device. Furthermore, scratching assay performed on fi broblasts treated with 
all four NTs, demonstrates that NGF, BDNF or NT3 also induce fi broblasts migration. 
These data clearly indicate that the NT network in the skin could be responsible for 
a variety of functions, from interference with UV damage to melanogenesis, from 
regulation of contractile properties of the dermis to control of epidermal homeostasis.
Skin mast cells and cutaneous sensory nerves – duo infernale of pruritus
M. Maurer Department of Dermatology and Allergy, Allergie-Centrum-Charité, 
Charité – Universitätsmedizin Berlin, Germany
Mast cells (MCs) are key contributors to many chronic infl ammatory and pruritic skin 
conditions such as urticaria and atopic dermatitis that are strongly modulated by 
neurogenic signals. Interestingly, there is a close relation of skin MCs and cutaneous 
sensory nerves (SNs) and MCs and SNs share a number of activating signals and 
mediators, for some of which both cell types express receptors. Interestingly, a 
number of recent studies have identifi ed and characterized novel and relevant 
pathways of MC and SN interactions. SNs were found to increase MC activation 
induced by IgE and allergen, and MC-mediated infl ammation as assessed by using 
mice that had been subjected to denervation by surgical ablation of their cutaneous 
SNs. Vice versa, capsaicin treatment, which is known to release neuropeptides from 
SNs, was found to induce markedly reduced skin infl ammation in MC-defi cient 
mice, which indicates that MCs contribute to the induction of SN-dependent 
infl ammation. In addition, MCs were found to control the levels of the neuropeptide 
endothelin-1, which is upregulated in various infl ammatory skin conditions. This 
novel MC function was shown to involve the release of pre-stored MC proteases 
and this mechanism proved to contribute to the control of endothelin-1-mediated 
infl ammation in vivo. Taken together, these observations show that MCs and SNs 
work as functional units in the induction and termination of pruritic infl ammatory 
skin reactions. The bidirectional interaction of MCs and SNs in the induction and 
control of pruritus and cutaneous infl ammation may provide novel therapeutic 
targets for the treatment of various chronic infl ammatory and pruritic skin diseases. 
Neuroreceptors involved in pruriception
S. Ständer Competence Center Pruritus, Department of Dermatology, University 
Hospital Münster, Germany
Itch was regarded for a long time as subspecialty of pain. Now it had become clear 
that pruriception is mediated by specialized peripheral and central neurons. However, 
nociception and pruriception show overlapping immunoneurological mechanisms 
and central perception areas. Unmyelinated skin C-fi bers of different classes are 
involved in induction of several itch qualities. Mechano-insensitive C-fi bers express 
the histamine receptor and mediate almost pure itch. Histamine is involved for 
example in urticaria-induced itching and may be suppressed with antihistamines. 
Only recently, mechano-responsive polymodal C-fi bers were identifi ed to mediate 
next to pain also itch. These intraepidermal C-fi bers were further identifi ed to express 
several receptors involved in pruriception. For example, the transient receptor potential 
vanilloid 1 (TRPV1) may induce burning pain and aggravate pruritus. Thus, targeting 
the receptor by its ligand capsaicin may serve as therapeutic intervention in chronic 
pain and pruritus. Also endothelin receptors and the proteinase activated- receptor 2 
(PAR-2) are expressed on the mechano-responsive polymodal C-fi bers and mediate 
itch. Current investigations disclosed that many of the involved neuroreceptors are 
co-expressed, interact and potentate their effects. As a consequence, chronifi cation 
of the symptoms is facilitated. Mediators of infl ammatory cells such as bradykinin 
and prostaglandin further contribute to chronifi cation by affecting neuroreceptors 
and by converting their threshold. Moreover, nerve growth factor (NGF) has a 
high impact on neuroreceptors as well as on neuroanatomy and was described 
to be a major mediator in chronic pruritic diseases such as prurigo nodularis and 
atopic dermatitis. The opposite, neuroreceptors such as cold receptors (TRPA1, 
TRPM8), opioid receptor and cannabinoid receptors may interrupt pruriception and 
therefore represent novel targets for new therapeutical modalities in chronic pruritus.
Alpha-MSH and fragments: mediators of neuroinfl ammation with a therapeutic 
potential
T.A. Luger Department of Dermatology, University of Münster, Germany
Neuropeptides are now well appreciated to exert cytokine like effects and to 
function as mediators of immunity and infl ammation. Among these neuromediators 
α-melanocyte-stimulating hormone (α-MSH) derived from the proopiomelanocortin 
was found to exert potent immuno-regulatory and anti-infl ammatory activities. The 
biologic activities of α-MSH are exerted via direct effects on cells of the immune 
system as well as indirectly via affecting the function of resident non-immune cells. 
Most of these effects are mediated via specifi c melanocortin receptors (MC-R) in 
particular MC-1R and MC-3R which are expressed on both immunocompetent as 
well as non-immune cells. α-MSH affects several pathways implicated in regulation of 
infl ammatory responses such as NF-κB activation, expression of adhesion molecules 
and chemokine receptors, production of proinfl ammatory cytokines and chemokines. 
Thus α-MSH modulates the proliferation, activity, and migration of infl ammatory 
cells as well as programmed cell death. Moreover, α-MSH prevents the maturation 
of dendritic cells (DC) and thereby triggers the generation of a subset of regulatory 
T-cells. The anti-infl ammatory and immuno-modulatory effects of α-MSH have been 
confi rmed in several animal models of infl ammation such as irritant and allergic contact 
dermatitis, cutaneous vasculitis, asthma, infl ammatory bowel disease and rheumatoid 
arthritis. Most of the anti-infl ammatory activities of α-MSH can be attributed to its 
C-terminal tripeptide KPV. K(D)PT, a derivative of KPV corresponding to the amino 
acid 193-195 of IL-1β, is currently emerging as another tripeptide with potent anti-
infl ammatory effects. The anti-infl ammatory potential together with the favourable 
physiochemical properties most likely will allow these agents to be developed for the 
treatment of infl ammatory skin, eye and bowel diseases, allergic asthma, and arthritis.
Catecholamines and stress
R.R. Isseroff Davies, CA, USA
Stress, both acute and chronic, can impair cutaneous wound repair, 
and this has previously been mechanistically ascribed to stress-induced 
elevations of cortisol. Our work supports an alternate explanation: that 
the stress-induced hormone epinephrine directly impairs keratinocyte
motility and wound re-epithelialization. We have proposed the burn wound 
as a prototype of a high-stress, high-epinephrine, wound environment. 
When human keratinocytes are cultured in medium in which epinephrine 
levels are elevated to the range found in burn-stressed animals, their
migratory rate is profoundly decreased. This impairment is reversed by 
β2AR antagonists, is absent in murine keratinocytes that are genetically 
depleted of the β2AR. Activation of the β2AR in cultured keratinocytes 
signals the down-regulation of the AKT pathway, accompanied by a
stabilization of the actin cytoskeleton and an increase in focal 
adhesion formation, resulting in a nonmigratory phenotype. Burn 
wound injury in excised human skin also rapidly up-regulates the
intra-epithelial expression of the epinephrine synthesizing enzyme 
phenylethanolamine-N-methyltransferase, and tissue levels of epinephrine 
rise dramatically (15-fold) in the burn wounded tissue.  Finally, using an 
animal burn wound model (20% body surface in mice), we found that
systemic treatment with βAR antagonists results in a signifi cant increase  in the rate 
of burn wound re-epithelialization.  This work demonstrates an alternate pathway 
by which stress can impair healing: by stress-induced elevation of epinephrine 
levels resulting in activation of the keratinocyte β2AR and the impairment of cell 
motility and wound re-epithelialization. Furthermore, since the burn wound 
locally generates epinephrine in response to wounding, epinephrine levels are 
locally, as well as systemically, elevated, and wound healing is impacted by 
these dual mechanisms. Treatment with beta adrenergic antagonists signifi cantly 
improves the rate of burn wound re-epithelialization. This work suggests that 
specifi c β2AR antagonists may be apt, near-term translational therapeutic 
targets for enhancing burn wound healing, and may provide a novel, low-
cost, safe approach to improving skin wound repair in the stressed individual.
“fMRI brain scan studies in dermatology”
C.E.M. Griffi ths University of Manchester, Manchester, UK
Functional magnetic resonance imaging (fMRI) of the brain is able to anatomically 
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map areas responsible for a variety of cerebral functions.  The technique is 
dependent on blood oxygen levels.  We have used fMRI to investigate whether 
the social impact of psoriasis is associated with altered cognitive processing 
of the expression of disgust.  We demonstrated that psoriasis patients have 
signifi cantly smaller signal responses to disgusted as compared to neutral facial 
expression in the bilateral insulae as compared with healthy controls.  There 
was no difference between the groups in terms of processing of fearful facial 
expressions.  This would indicate that patients develop a coping mechanism 
by blocking processing of disgusted facial expressions encountered in others. 
We have also investigated the cerebral processing of itch using a placebo–
controlled fMRI experimental design and a novel time-series analysis technique 
using either histamine or saline injected into the volar left forearm.  During the 
histamine scan, all volunteers perceived itch and developed a wheal and fl are 
reaction.  In contrast in the saline control there was minimal itch, and wheal and 
fl are reactions were not observed.  We showed that there was involvement of the 
bilateral pre-frontal motor cortex superior and mid-temporal gyri, cerebellum, 
anterior insula and postcentral gyri in itch processing.  These studies, taken 
together, provide further evidence for the presence of a “brain-skin axis”.
Psychoneuroimmunology – clinical implications
W. Glinski Department of Dermatology, Medical University of Warsaw, Poland
Progress in basic science resulted in the discovery of many mechanisms related to 
neuropeptides in the skin. These substances are  released from peripheral cutaneous 
nerves during the physiological response to various nociceptive stimuli as well 
as in disease states. Both histamine from mast (MC) cells and endothelin 1 from 
endothelial cells and mast cells may induce neurogenic infl ammation through their 
specifi c receptors on cutaneous sensory fi bres H1 and ETA respectively. Neurogenic 
infl ammation is altered in both psoriasis and atopic dermatitis (AD). The activation 
of   vanilloid receptor VR1 is related to pruritus/burning and erythema induced 
during external calcineurin inhibitor treatment in numerous dermatological diseases. 
Keratinocytes (KC) are the source of nerve growth factor (NGF), that is neurotropin 
responsible for cutaneous     nociception, nerve development and reconstruction of 
peptinergic C fi bres  after injury. Other receptors i.e.  thermoreceptor on sensory C and 
fi lters Aδ fi bres, namely VR1 (transient receptor potential, TRPV1) and cold receptors 
(TRPM8) on myelinated  Aδ fi bres might be responsible for itching and burning 
sensation. Endogenous opioid system is involved in antinociceptive pruritogenic 
effect in the skin after opioid binding to receptor: β-endorphin-MOR (µ),  enkephalins 
– KOR (δ), and dynorphins – KOR (κ). β-endorphin upregulates some functions of 
keratinocytes – TGFβR2 expression, cytokeratin 16 production and migration of KC. It 
stimulates proliferation of melanocytes and plays a role in psoriasis, BCC and wound 
healing. Chronic itch was related rather to MOR, whereas acute itching to the activity 
of KOR agonists similarly to histamine, prostaglandins, leukotrienes, SP and CGRP, 
tryptase etc. Important propruritic factor in the pathogenesis of AD are proteinase 
activation receptors (PAR2) on skin nerves, which are stimulated by tryptase from 
MC or by other neutral proteinases. New strategy to suppress nociception is 
N-palmitoylethanolamin (PEA) which bind cannabinoid receptors CB1 and CB2 
which is followed by release of opioids to the skin. These complicated network of 
neuropeptides is modulating both KC function and immunological response in the skin.
ItchyQoL and CU-Q2oL – novel instruments for measuring quality of life in patients 
with pruritic skin disorders
M. Metz Department of Dermatology and Allergy, Allergie-Centrum-Charité, Charité 
– Universitätsmedizin Berlin, Germany
Pruritus is a widely spread symptom in numerous dermatologic and systemic diseases 
that may have an enormous impact on patients’ daily life. The high individual burden 
of chronic pruritus along with the diffi culty in objectively measuring pruritus intensity 
makes the assessment of quality of life (QoL) a suitable instrument to evaluate the 
impact of itch and the effi cacy of its therapy upon a patient. Chronic spontaneous 
urticaria (CU) is a common skin disorder which is characterized by intense pruritus 
and spontaneously arising wheals and/or angioedema, occurring on a regular basis 
for longer than 6 weeks. Patients often suffer from CU for many years, and it has 
repeatedly been found that CU has a substantial impact on patient quality-of-life. In 
general, a better understanding of QoL in pruritus and CU patients is necessary for 
both clinical research and routine patient care. In clinical research, QoL measurements 
provide a rich evaluation of the benefi ts of a treatment, as experienced from the 
patient’s perspective. In routine care, QoL measures can provide physicians with a 
better understanding of the ways in which they can help their patients. Although 
there are many excellent general and dermatological QoL questionnaires, there were 
until recently no questionnaires available specifi cally designed for pruritus or CU 
patients which address the aspects of QoL most relevant to their condition. In the 
last years, ItchyQoL, an instrument for assessing the pruritus-specifi c QoL, and CU-
Q2oL, a tool to evaluate the impact of CU on QoL have been developed in English 
and Italian, respectively, and proven to be reliable, valid and responsive. We have 
translated both original instruments into German, culturally adapted, retranslated 
and tested them in cooperation with the original authors. Further translations of 
these questionnaires into various different languages are now of importance as these 
tools can then be used for the conduction of international studies with pooled data 
which would allow, for example, for an objective evaluation of the impact of certain 
treatments on the QoL in large numbers of pruritus or CU patients from different 
nationalities. Future use of these patient-related outcome measures may improve 
effi cacy of treatment in pruritus and CU patients and generate direct patient benefi t.
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